A strategy for producing predicted polymorphs: catemeric carbamazepine form V
- 26 May 2011
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 47 (25) , 7074-7076
Abstract
A computationally assisted approach has enabled the first catemeric polymorph of carbamazepine (form V) to be selectively formed by templating the growth of carbamazepine from the vapour phase onto the surface of a crystal of dihydrocarbamazepine form II.Keywords
This publication has 25 references indexed in Scilit:
- Anion-switchable supramolecular gels for controlling pharmaceutical crystal growthNature Chemistry, 2010
- Computed Crystal Energy Landscapes for Understanding and Predicting Organic Crystal Structures and PolymorphismAccounts of Chemical Research, 2008
- Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepineCrystEngComm, 2008
- Polymorph control: past, present and futureDrug Discovery Today, 2008
- One-solvent polymorph screen of carbamazepineInternational Journal of Pharmaceutics, 2008
- Crystal Engineering: A Holistic ViewAngewandte Chemie International Edition, 2007
- Control and prediction of packing motifs: a rare occurrence of carbamazepine in a catemeric configurationCrystEngComm, 2006
- An Automated Parallel Crystallisation Search for Predicted Crystal Structures and Packing Motifs of CarbamazepineJournal of Pharmaceutical Sciences, 2006
- An orthorhombic polymorph of 10,11-dihydrocarbamazepineActa Crystallographica Section C Crystal Structure Communications, 2006
- Structural Studies of the Polymorphs of Carbamazepine, Its Dihydrate, and Two SolvatesOrganic Process Research & Development, 2005